2 Companies Trying To Change U.S. Healthcare

Though it's no small task, here are two companies that are trying to change the way Americans think about their healthcare.
July 15, 2019
Unlock Free Stock Insights + 50% Off Discount Code!
Join thousands of savvy investors and get:
  • Weekly Stock Picks: Handpicked from 60,000 global options.
  • Ten Must-Have Stocks: Essential picks to hold until 2034.
  • Exclusive Stock Library: In-depth analysis of 60 top stocks.
  • Proven Success: 10-year track record of outperforming the market.
Sign up to our mailing list now and enjoy a 50% discount on premium services!
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy and Terms of Use.

"America's healthcare system is neither healthy, caring, nor a system."
-- Walter Cronkite

There are few issues in the United States more divisive than healthcare. Some agree with Walter Cronkite, saying the whole arrangement is intolerably inefficient and expensive. Others point out the exceptional quality of care Americans receive in return for their money.

While Americans may not see eye-to-eye on the subject's political implications, there's one thing everyone can agree on -- the face of the sector is rapidly changing. With innovations being made every year in medical technology and pharmacology and a greater number of elderly patients in the U.S. than ever before, now is as good a time as ever to invest in the companies that are riding these technological and demographic waves.

1. Teladoc

Teladoc (NYSE: TDOC) is a New York-based company that provides services in the growing telehealth industry. In case you've never heard of it, telehealth refers to medical technologies that allow patients to access remote care through mobile devices and the internet.

This means that if you're concerned about your health, you can contact a variety of licensed medical professionals electronically, avoiding the cumbersome process of making a physical appointment. Teladoc goes a step further than that, allowing patients to submit their medical records, access specialized services, and even receive prescriptions through its platform.

Launched in 2002, Teladoc is actually the oldest company of its kind, a true innovator in the telemedicine space. It derives its revenue from subscription-fees, usually paid by corporate clients (including as much as 40% of the Fortune 500) on behalf of their employees. Users can also pay a one-time visit fee to access a range of services.

Following several successful rounds of funding, the company went public in 2015 and has been going from strength to strength since then. Indeed, last year, it pulled in revenue of $418 million, representing year-on-year growth of 79%. We've picked it as one of our 3 stocks for an aging population.

2. Evolent Health

Evolent Health (NYSE: EVH) was founded in 2011 as an alliance between the University of Pittsburgh Medical Center and the medical consulting firm, Advisory Board. The company's seemingly-impossible goal is to improve the quality of healthcare while simultaneously slashing costs.

How does it plan to do this?

By investing in its data analytics wing, the company can perform targeted interventions for its patients based on their medical records and other factors, as well as tracking their visits and outcomes.

The company went public in 2015, closing the day with a $1 billion market cap. At the time of its IPO, Evolent had secured ten contracts with institutions such as Piedmont WellStar and Indiana University. Evolent's contracts are not typical for consulting firms, however. The company likes to stress that its partnerships are intended to last decades rather than years.

As well as its commitment to fulfilling long-term contracts, Evolent also emphasizes the human side of its business. The word 'care' in healthcare is not incidental, after all.

In the words of CEO Frank Williams, Evolent owed its rapid success to the management team's hands-on approach to its clients: "We were in the field, getting real feedback -- not in a lab."

Read More From MyWallSt




MyWallSt operates a full disclosure policy. MyWallSt staff currently hold long positions in Evolent Health and Teladoc. Read our full disclosure policy here.


Unlock Free Stock Insights +50% Off Discount Code!
Join thousands of savvy investors and get:
  • Weekly Stock Picks: Handpicked from 60,000 global options.
  • Ten Must-Have Stocks: Essential picks to hold until 2034.
  • Exclusive Stock Library: In-depth analysis of 60 top stocks.
  • Proven Success: 10-year track record of outperforming the market.
Sign up to our mailing list now and enjoy a 50% discount on premium services!
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy and Terms of Use.

The Home of Successful Investing.

© 2024 MyWallSt Ltd. All rights reserved.


Services

Content

Social

Company

Support

Resources


This website is operated by MyWallSt Ltd (“MyWallSt”). MyWallSt is a publisher and a technology platform, not a registered broker-dealer or registered investment adviser, and does not provide investment advice. All information provided by MyWallSt Limited is of a general nature for information and education purposes, and you should not construe any such information as investment advice. MyWallSt Limited does not take your specific needs, investment objectives or financial situation into consideration, and any investments mentioned may not be suitable for you. You should always carry out your own independent verification of facts and data before making any investment decisions, as we cannot guarantee the accuracy or completeness of any information we publish and any opinions that we publish may be wrong and may change at any time without notice. If you are unsure of any investment decision you should seek a professional financial advisor. MyWallSt Limited is not a registered investment adviser and we do not provide regulated investment advice or recommendations. MyWallSt Limited is not regulated by the Central Bank of Ireland. MyWallSt Limited may provide hyperlinks to web sites operated by third parties. Your use of third party web sites and content, including without limitation, your use of any information, data, advertising, products, or other materials on or available through such web sites, is at your own risk and is subject to the third parties' terms of use.